ACSESLY
DEAD

Serial Number

90322048

Owner

GW Research Limited

Attorney

Michael T. Olsen

Filing Date

Nov 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ACSESLY Trademark

Serial Number: 90322048

ACSESLY is a trademark filed by GW Research Limited on November 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Trademark Details

Filing Date

November 16, 2020

Registration Date

Not Registered

Published for Opposition

June 15, 2021

Goods & Services

Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; pure extracts of medicinal plants and herbs for medical purposes; dietetic foodstuffs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 16, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 16, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2024 EXRA
SOU EXTENSION 5 GRANTED
Feb 6, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2024 AITU
SOU EXTENSION 5 FILED
Jan 18, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 14, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jul 12, 2023 EX4G
SOU EXTENSION 4 FILED
Jul 12, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 12, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 10, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 10, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 10, 2022 EXRA
SOU EXTENSION 2 GRANTED
Aug 8, 2022 EX2G
SOU EXTENSION 2 FILED
Aug 8, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 3, 2022 EXRA
SOU EXTENSION 1 GRANTED
Feb 1, 2022 EX1G
SOU EXTENSION 1 FILED
Feb 1, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 1, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 10, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 15, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2021 CNEA
ASSIGNED TO EXAMINER
Apr 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 19, 2020 NWAP